ATE357452T1 - Sialyl-lewisa und sialyl lewisx epitop-analoge - Google Patents

Sialyl-lewisa und sialyl lewisx epitop-analoge

Info

Publication number
ATE357452T1
ATE357452T1 AT97901546T AT97901546T ATE357452T1 AT E357452 T1 ATE357452 T1 AT E357452T1 AT 97901546 T AT97901546 T AT 97901546T AT 97901546 T AT97901546 T AT 97901546T AT E357452 T1 ATE357452 T1 AT E357452T1
Authority
AT
Austria
Prior art keywords
sialyl
lewisa
lewisx
epitop
analogue
Prior art date
Application number
AT97901546T
Other languages
English (en)
Inventor
Reinhold Oehrlein
Original Assignee
Glycomimetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomimetics Inc filed Critical Glycomimetics Inc
Application granted granted Critical
Publication of ATE357452T1 publication Critical patent/ATE357452T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97901546T 1996-01-30 1997-01-17 Sialyl-lewisa und sialyl lewisx epitop-analoge ATE357452T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH23096 1996-01-30

Publications (1)

Publication Number Publication Date
ATE357452T1 true ATE357452T1 (de) 2007-04-15

Family

ID=4182259

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97901546T ATE357452T1 (de) 1996-01-30 1997-01-17 Sialyl-lewisa und sialyl lewisx epitop-analoge

Country Status (6)

Country Link
US (1) US6169077B1 (de)
EP (1) EP0886640B1 (de)
AT (1) ATE357452T1 (de)
AU (1) AU1542397A (de)
DE (1) DE69737496D1 (de)
WO (1) WO1997028173A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756489B1 (en) * 1997-08-08 2004-06-29 Aventis Pharma Deutschland Gmbh Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
US7481790B2 (en) * 2000-12-27 2009-01-27 Advanced Cardiovascular Systems, Inc. Vessel enlargement by arteriogenic factor delivery
JP5183010B2 (ja) 2002-05-16 2013-04-17 グリコミメティクス， インコーポレイテッド セレクチンによって媒介される機能を阻害するための化合物および方法
AU2003245595A1 (en) * 2002-07-03 2004-01-23 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving angiogenesis
WO2004058304A1 (en) * 2002-12-20 2004-07-15 Glycomimetics, Inc. Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
DE602004011272T2 (de) 2003-11-19 2008-12-24 Glycomimetics, Inc. Spezifischer antagonist sowohl für e- als auch p-selektine
CA2546784A1 (en) * 2003-11-19 2005-06-16 Glycomimetics, Inc. Glycomimetic antagonists for both e- and p-selectins
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
US20090036386A1 (en) * 2005-05-25 2009-02-05 Glycomimetics, Inc Heterobifunctional compounds for selectin inhibition
WO2007021721A2 (en) 2005-08-09 2007-02-22 Glycomimetics, Inc. Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
SI2264043T1 (en) 2005-09-02 2018-01-31 Glycomimetics, Inc. HETEROBIFUNCTIONAL PAN-SELECTINE INHIBITORS
US20090176717A1 (en) * 2006-06-01 2009-07-09 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
US7964569B2 (en) 2006-10-12 2011-06-21 Glycomimetics, Inc. Glycomimetic replacements for hexoses and N-acetyl hexosamines
WO2008100453A1 (en) * 2007-02-09 2008-08-21 Glycomimetics, Inc. Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
US8039442B2 (en) * 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
US8895510B2 (en) 2008-04-08 2014-11-25 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
US8518896B2 (en) * 2008-06-13 2013-08-27 Glycomimetics, Inc. Treatment of cancers of the blood using selected glycomimetic compounds
AU2010241807B2 (en) * 2009-05-01 2014-08-14 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
US8921328B2 (en) 2010-09-14 2014-12-30 Glycomimetics, Inc. E-selectin antagonists
EP2794626B3 (de) 2011-12-22 2020-08-05 GlycoMimetics, Inc. E-selectin-antagonistenverbindungen
GB201214736D0 (en) * 2012-08-17 2012-10-03 Isis Innovation Inflammation imaging and therapy
HUE038423T2 (hu) 2012-12-07 2018-10-29 Glycomimetics Inc E-szelektin antagonistákat felhasználó vegyületek, készítmények és eljárások vérképzõ sejtek mobilizációjára
CN107108679B (zh) 2014-12-03 2020-10-23 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂
WO2017127422A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
BR112019006642A2 (pt) 2016-10-07 2019-07-02 Glycomimetics Inc antagonistas multiméricos de e-selectina altamente potentes
CA3054605A1 (en) 2017-03-15 2018-09-20 Glycomimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
EP3717013A1 (de) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Verfahren zur mobilisierung von knochenmarkinfiltrierenden lymphozyten und deren verwendung
US11548908B2 (en) 2017-12-29 2023-01-10 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
AU2019230013A1 (en) 2018-03-05 2020-09-10 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925796A (en) * 1986-03-07 1990-05-15 Massachusetts Institute Of Technology Method for enhancing glycoprotein stability
SE9301677L (sv) 1993-05-14 1994-11-18 Kurt G I Nilsson Syntesmetod
CN1125449A (zh) 1993-05-14 1996-06-26 萨依特尔有限公司 作为细胞粘附抑制剂的唾液基Lex类似物

Also Published As

Publication number Publication date
EP0886640A1 (de) 1998-12-30
EP0886640B1 (de) 2007-03-21
US6169077B1 (en) 2001-01-02
WO1997028173A1 (en) 1997-08-07
DE69737496D1 (de) 2007-05-03
AU1542397A (en) 1997-08-22

Similar Documents

Publication Publication Date Title
DE69737496D1 (de) SIALYL-LEWISa UND SIALYL LEWISx EPITOP-ANALOGE
ATE397005T1 (de) Sialyl-lewisa und sialyl-lewisx epitope analoge
ES2101499T3 (es) Fibras.
ES2128097T3 (es) Combinaciones de herbicidas de sulfonilurea con antidotos.
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
NO974510D0 (no) Synergistiske blandinger av zidovudin, 1592U89 og 3TC eller FTC
AU1198697A (en) Stabilizers for live vaccines
NO990497L (no) Modifiserte oligosakkarider
ES2171506T3 (es) Mezclas de resinas de poli(ester carbonato) y de polieterimida resistentes al autoclave.
BR8802492A (pt) Composicao esterilizante e de alto grau desinfetante,inodora
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
NO904676L (no) Optisk forsterkningsenhet med lav stoey og med refleksjon av den pumpende effekt.
DE69425433D1 (de) Getränke-stabilisierungssystem
BR9510604A (pt) Aperfeiçoamento do rendimento de plantas
FI73995B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 6,11-dihydro-dibenso-/b,e/-tiepin-11-n-alkyl- norskopinetrar.
ES2179113T3 (es) Composiciones dentales economicas que contienen novedosos aluminosilicatos de sodio.
DE69023411D1 (de) Vektorquantizierungskodierer und Dekodierer.
ES2106920T3 (es) Composicion que permite estabilizar termicamente las proteinas y producto obtenido de este modo.
UY24654A1 (es) Composición de vacuna contra la malaria
EP0667790A4 (de) Regulation der zellulären invasivität.
ES2167748T3 (es) Derivados del polisacarido k5 con actividad anticoagulante.
FI895039A0 (fi) Metoder foer behandling och foerebyggande av pneumocystis carinii-lunginflammation och andra sjukdomar samt foereningar och kompositioner, som anvaends i naemnda metoder.
EP1666057A3 (de) Ein azellulärer Impfstoff der Bordetella pertussis Antigene enthält
ES2165551T3 (es) Bacillus sp. ac13 alcalofilo y xilanasa obtenida a partir de dicha especie.
DK0831722T3 (da) Gelsystem, som omfatter carrageenan og kokosnødendosperm

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties